Efficacy of Long-Term Treatment with Once Daily Baricitinib 2 mg in Patients with Active Rheumatoid Arthritis: Post Hoc Analysis of Two 24-week, Phase III, Randomized, Controlled Studies and One Long-term Extension Study
mediaposted on 2021-05-20, 13:54 authored by Adis journals on behalf of, Alvin F. Wells, Bochao Jia, Li Xie, Guillermo J. Valenzuela, Edward C. Keystone, Zhanguo Li, Amanda K. Quebe, Kirstin Griffing, Susan Otawa, Boulos Haraoui
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.